Showing results (461-470 of 586) with videos related to

Sort By:
Pageof 59
Journal of Clinical Microbiology|October 11, 2019
Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter CutoffsMeklit Workneh, Ruibin Wang, Abida Q Kazmi, et al.
Journal of Clinical Microbiology|July 7, 2018
Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebrospinal Fluid DiagnosticsPatricia J Simner, Heather B Miller, Florian P Breitwieser, et al.
Thorax|April 28, 2017
Do guidelines for treating chest disease in children use Cochrane Reviews effectively? A systematic reviewAndrew P Prayle, Tessy Cox, Sherie J Smith, et al.
JCI Insight|October 4, 2019
Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficileJulia L Drewes, Alina Corona, Uriel Sanchez, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2018
Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniaePatricia J Simner, Annukka A R Antar, Stephanie Hao, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 1, 2008
Identification of superoxide dismutase as a potential urinary marker of carbon tetrachloride-induced hepatic toxicityR Smyth, J A Turton, C J Clarke, et al.
Brain Communications|April 10, 2023
Preimplantation or gestation/lactation high-fat diet alters adult offspring metabolism and neurogenesisDiego A Ojeda, Oliver Hutton, Robert Hopkins, et al.
Research Involvement and Engagement|August 28, 2019
Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosisN J Rowbotham, S J Smith, Z C Elliott, et al.
Microbiology Spectrum|August 22, 2023
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiomeRyan Marsh, Claudio Dos Santos, Liam Hanson, et al.
Pageof 59